GENELUX Corp(GNLX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

GENELUX Corp (GNLX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GNLX at 12.3/100 on a 32-signal composite quality model, placing it at rank #2,888 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), GENELUX Corp reports net income of $-9.5M, free cash flow of $-8.0M. Top institutional holders of GNLX by reported 13-F value include WOODWARD DIVERSIFIED CAPITAL, VANGUARD CAPITAL MANAGEMENT, Bleichroeder, based on the most recent SEC filings. GNLX trades on the Nasdaq exchange and files with the SEC under CIK 1231457. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GNLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GENELUX Corp directly from SEC EDGAR.